nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—BRAF—adrenal gland cancer	0.713	0.844	CbGaD
Dabrafenib—ABCB1—adrenal gland cancer	0.132	0.156	CbGaD
Dabrafenib—NEK11—adrenal gland—adrenal gland cancer	0.00354	0.116	CbGeAlD
Dabrafenib—SLC22A8—urine—adrenal gland cancer	0.00317	0.104	CbGeAlD
Dabrafenib—LIMK1—adrenal gland—adrenal gland cancer	0.00253	0.0831	CbGeAlD
Dabrafenib—BRAF—pituitary gland—adrenal gland cancer	0.00175	0.0575	CbGeAlD
Dabrafenib—CYP3A4—urine—adrenal gland cancer	0.00157	0.0516	CbGeAlD
Dabrafenib—BRAF—adrenal gland—adrenal gland cancer	0.00157	0.0514	CbGeAlD
Dabrafenib—SLCO1B3—pituitary gland—adrenal gland cancer	0.00151	0.0496	CbGeAlD
Dabrafenib—SIK1—gonad—adrenal gland cancer	0.0015	0.0493	CbGeAlD
Dabrafenib—SIK1—cardiac atrium—adrenal gland cancer	0.0015	0.0493	CbGeAlD
Dabrafenib—SIK1—pituitary gland—adrenal gland cancer	0.00147	0.0481	CbGeAlD
Dabrafenib—RAF1—adrenal cortex—adrenal gland cancer	0.00145	0.0474	CbGeAlD
Dabrafenib—SIK1—adrenal gland—adrenal gland cancer	0.00131	0.043	CbGeAlD
Dabrafenib—RAF1—gonad—adrenal gland cancer	0.0012	0.0393	CbGeAlD
Dabrafenib—RAF1—cardiac atrium—adrenal gland cancer	0.0012	0.0392	CbGeAlD
Dabrafenib—RAF1—pituitary gland—adrenal gland cancer	0.00117	0.0383	CbGeAlD
Dabrafenib—RAF1—adrenal gland—adrenal gland cancer	0.00104	0.0342	CbGeAlD
Dabrafenib—ABCG2—adrenal cortex—adrenal gland cancer	0.000598	0.0196	CbGeAlD
Dabrafenib—CYP2C8—pituitary gland—adrenal gland cancer	0.000497	0.0163	CbGeAlD
Dabrafenib—ABCG2—pituitary gland—adrenal gland cancer	0.000483	0.0158	CbGeAlD
Dabrafenib—ABCG2—adrenal gland—adrenal gland cancer	0.000432	0.0142	CbGeAlD
Dabrafenib—ABCB1—adrenal cortex—adrenal gland cancer	0.000295	0.00967	CbGeAlD
Dabrafenib—ABCB1—gonad—adrenal gland cancer	0.000244	0.00801	CbGeAlD
Dabrafenib—ABCB1—pituitary gland—adrenal gland cancer	0.000238	0.00781	CbGeAlD
Dabrafenib—ABCB1—adrenal gland—adrenal gland cancer	0.000213	0.00698	CbGeAlD
Dabrafenib—BRAF—Senescence and Autophagy in Cancer—TP53—adrenal gland cancer	9.3e-05	0.000749	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—BRAF—adrenal gland cancer	9.19e-05	0.00074	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—BAD—adrenal gland cancer	9.15e-05	0.000737	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	9.11e-05	0.000734	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CDC42—adrenal gland cancer	9.08e-05	0.000731	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—GNRHR—adrenal gland cancer	9.03e-05	0.000727	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	9.01e-05	0.000726	CbGpPWpGaD
Dabrafenib—LIMK1—Axon guidance—EGFR—adrenal gland cancer	9e-05	0.000724	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by VEGF—CTNNB1—adrenal gland cancer	9e-05	0.000724	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—SH3KBP1—adrenal gland cancer	8.98e-05	0.000723	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—BRAF—adrenal gland cancer	8.82e-05	0.00071	CbGpPWpGaD
Dabrafenib—BRAF—Focal Adhesion—CTNNB1—adrenal gland cancer	8.7e-05	0.000701	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	8.58e-05	0.000691	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	8.57e-05	0.00069	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—CDC42—adrenal gland cancer	8.55e-05	0.000689	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—SH3KBP1—adrenal gland cancer	8.39e-05	0.000676	CbGpPWpGaD
Dabrafenib—BRAF—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	8.37e-05	0.000674	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—SPARC—adrenal gland cancer	8.36e-05	0.000674	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—BRAF—adrenal gland cancer	8.33e-05	0.000671	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	8.3e-05	0.000668	CbGpPWpGaD
Dabrafenib—RAF1—Disease—SH3KBP1—adrenal gland cancer	8.29e-05	0.000668	CbGpPWpGaD
Dabrafenib—BRAF—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	8.28e-05	0.000667	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	8.24e-05	0.000664	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—CTNNB1—adrenal gland cancer	8.1e-05	0.000653	CbGpPWpGaD
Dabrafenib—RAF1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	7.99e-05	0.000644	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—ZNRF3—adrenal gland cancer	7.89e-05	0.000635	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways in Glioblastoma—TP53—adrenal gland cancer	7.84e-05	0.000632	CbGpPWpGaD
Dabrafenib—BRAF—EGF/EGFR Signaling Pathway—EGFR—adrenal gland cancer	7.83e-05	0.000631	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR—EGFR—adrenal gland cancer	7.83e-05	0.000631	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	7.81e-05	0.000629	CbGpPWpGaD
Dabrafenib—RAF1—Disease—ZNRF3—adrenal gland cancer	7.8e-05	0.000628	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—SDHB—adrenal gland cancer	7.69e-05	0.000619	CbGpPWpGaD
Dabrafenib—RAF1—ErbB1 downstream signaling—EGFR—adrenal gland cancer	7.67e-05	0.000617	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—EGFR—adrenal gland cancer	7.61e-05	0.000613	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	7.58e-05	0.000611	CbGpPWpGaD
Dabrafenib—RAF1—BDNF signaling pathway—CTNNB1—adrenal gland cancer	7.51e-05	0.000605	CbGpPWpGaD
Dabrafenib—RAF1—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	7.48e-05	0.000602	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—SDHD—adrenal gland cancer	7.38e-05	0.000594	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—RRM1—adrenal gland cancer	7.38e-05	0.000594	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR in disease—EGFR—adrenal gland cancer	7.3e-05	0.000587	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—CTNNB1—adrenal gland cancer	7.16e-05	0.000576	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—SDHB—adrenal gland cancer	7.12e-05	0.000574	CbGpPWpGaD
Dabrafenib—BRAF—Disease—SPRY2—adrenal gland cancer	7.06e-05	0.000569	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—PRKACA—adrenal gland cancer	7.06e-05	0.000569	CbGpPWpGaD
Dabrafenib—BRAF—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	6.96e-05	0.00056	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	6.94e-05	0.000559	CbGpPWpGaD
Dabrafenib—BRAF—Focal Adhesion—EGFR—adrenal gland cancer	6.89e-05	0.000555	CbGpPWpGaD
Dabrafenib—SLCO1B3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	6.81e-05	0.000549	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	6.7e-05	0.000539	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—BAD—adrenal gland cancer	6.6e-05	0.000531	CbGpPWpGaD
Dabrafenib—BRAF—Disease—MEN1—adrenal gland cancer	6.47e-05	0.000521	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	6.46e-05	0.00052	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—TP53—adrenal gland cancer	6.44e-05	0.000518	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—EGFR—adrenal gland cancer	6.42e-05	0.000517	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—TP53—adrenal gland cancer	6.39e-05	0.000514	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—PRKACA—adrenal gland cancer	6.36e-05	0.000512	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—BAD—adrenal gland cancer	6.34e-05	0.00051	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—GNRH1—adrenal gland cancer	6.33e-05	0.00051	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.33e-05	0.00051	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—GNRHR—adrenal gland cancer	6.25e-05	0.000503	CbGpPWpGaD
Dabrafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	6.16e-05	0.000496	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	6.15e-05	0.000495	CbGpPWpGaD
Dabrafenib—RAF1—Neuronal System—BRAF—adrenal gland cancer	6.13e-05	0.000493	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.11e-05	0.000492	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—CDC42—adrenal gland cancer	6.1e-05	0.000492	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—PRKACA—adrenal gland cancer	6.1e-05	0.000491	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	6.05e-05	0.000488	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—EGFR—adrenal gland cancer	6.05e-05	0.000488	CbGpPWpGaD
Dabrafenib—SLC22A8—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	6.03e-05	0.000486	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—CTNNB1—adrenal gland cancer	6.02e-05	0.000485	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—BRAF—adrenal gland cancer	6.01e-05	0.000484	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	5.99e-05	0.000483	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—CDC42—adrenal gland cancer	5.99e-05	0.000482	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SH3KBP1—adrenal gland cancer	5.81e-05	0.000468	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	5.79e-05	0.000466	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—EGFR—adrenal gland cancer	5.79e-05	0.000466	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—IGF2—adrenal gland cancer	5.77e-05	0.000465	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	5.76e-05	0.000464	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—GNAS—adrenal gland cancer	5.72e-05	0.000461	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—EGFR—adrenal gland cancer	5.7e-05	0.000459	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—EGFR—adrenal gland cancer	5.67e-05	0.000457	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—TSHR—adrenal gland cancer	5.65e-05	0.000455	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—MED12—adrenal gland cancer	5.5e-05	0.000443	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ZNRF3—adrenal gland cancer	5.46e-05	0.00044	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—EGFR—adrenal gland cancer	5.45e-05	0.000438	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—EGFR—adrenal gland cancer	5.42e-05	0.000436	CbGpPWpGaD
Dabrafenib—RAF1—EGF/EGFR Signaling Pathway—EGFR—adrenal gland cancer	5.42e-05	0.000436	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—GNRH1—adrenal gland cancer	5.41e-05	0.000435	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—EGFR—adrenal gland cancer	5.39e-05	0.000434	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CDC42—adrenal gland cancer	5.39e-05	0.000434	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—EGFR—adrenal gland cancer	5.37e-05	0.000432	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—TP53—adrenal gland cancer	5.36e-05	0.000432	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	5.33e-05	0.000429	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—EGFR—adrenal gland cancer	5.26e-05	0.000424	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CDC42—adrenal gland cancer	5.18e-05	0.000417	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.13e-05	0.000413	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—EGFR—adrenal gland cancer	5.05e-05	0.000406	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—EGFR—adrenal gland cancer	5.05e-05	0.000406	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—EGFR—adrenal gland cancer	5.05e-05	0.000406	CbGpPWpGaD
Dabrafenib—SLC22A6—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	5.03e-05	0.000405	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—EGFR—adrenal gland cancer	5e-05	0.000403	CbGpPWpGaD
Dabrafenib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	5e-05	0.000402	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—EGFR—adrenal gland cancer	4.97e-05	0.0004	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	4.96e-05	0.000399	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—SDHD—adrenal gland cancer	4.96e-05	0.000399	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—RRM1—adrenal gland cancer	4.96e-05	0.000399	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	4.95e-05	0.000399	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—SPRY2—adrenal gland cancer	4.95e-05	0.000398	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	4.94e-05	0.000398	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PRKACA—adrenal gland cancer	4.94e-05	0.000398	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—EGFR—adrenal gland cancer	4.94e-05	0.000397	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.92e-05	0.000396	CbGpPWpGaD
Dabrafenib—RAF1—Disease—SPRY2—adrenal gland cancer	4.89e-05	0.000394	CbGpPWpGaD
Dabrafenib—RAF1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	4.86e-05	0.000391	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TSHR—adrenal gland cancer	4.82e-05	0.000388	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—EGFR—adrenal gland cancer	4.77e-05	0.000384	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.77e-05	0.000384	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	4.75e-05	0.000382	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	4.67e-05	0.000376	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—SDHD—adrenal gland cancer	4.59e-05	0.00037	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—RRM1—adrenal gland cancer	4.59e-05	0.00037	CbGpPWpGaD
Dabrafenib—SLCO1B1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	4.58e-05	0.000369	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MEN1—adrenal gland cancer	4.53e-05	0.000365	CbGpPWpGaD
Dabrafenib—RAF1—Disease—MEN1—adrenal gland cancer	4.48e-05	0.000361	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	4.47e-05	0.00036	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—SDHB—adrenal gland cancer	4.42e-05	0.000356	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—TP53—adrenal gland cancer	4.42e-05	0.000356	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	4.32e-05	0.000348	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	4.32e-05	0.000348	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	4.3e-05	0.000346	CbGpPWpGaD
Dabrafenib—ABCG2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	4.24e-05	0.000341	CbGpPWpGaD
Dabrafenib—BRAF—Disease—CDC42—adrenal gland cancer	4.19e-05	0.000337	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CTNNB1—adrenal gland cancer	4.17e-05	0.000336	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—PRKACA—adrenal gland cancer	4.05e-05	0.000326	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PRKACA—adrenal gland cancer	4.01e-05	0.000323	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.99e-05	0.000321	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.92e-05	0.000316	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—SDHB—adrenal gland cancer	3.85e-05	0.00031	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—BAD—adrenal gland cancer	3.76e-05	0.000303	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—GNRH1—adrenal gland cancer	3.74e-05	0.000301	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—PRKACA—adrenal gland cancer	3.7e-05	0.000298	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—MED12—adrenal gland cancer	3.7e-05	0.000298	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—BAD—adrenal gland cancer	3.61e-05	0.000291	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.48e-05	0.00028	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—PRKACA—adrenal gland cancer	3.46e-05	0.000279	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—EGFR—adrenal gland cancer	3.44e-05	0.000277	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CDC42—adrenal gland cancer	3.44e-05	0.000277	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—MED12—adrenal gland cancer	3.42e-05	0.000276	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SPRY2—adrenal gland cancer	3.42e-05	0.000276	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PRKACA—adrenal gland cancer	3.42e-05	0.000275	CbGpPWpGaD
Dabrafenib—BRAF—Disease—TERT—adrenal gland cancer	3.36e-05	0.000271	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TSHR—adrenal gland cancer	3.34e-05	0.000269	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.3e-05	0.000266	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—EGFR—adrenal gland cancer	3.3e-05	0.000266	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—GNAS—adrenal gland cancer	3.28e-05	0.000264	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GNAS—adrenal gland cancer	3.25e-05	0.000262	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—ABCB1—adrenal gland cancer	3.19e-05	0.000257	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	3.16e-05	0.000254	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CDC42—adrenal gland cancer	3.14e-05	0.000253	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MEN1—adrenal gland cancer	3.14e-05	0.000252	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—EGFR—adrenal gland cancer	3.11e-05	0.000251	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CDC42—adrenal gland cancer	2.93e-05	0.000236	CbGpPWpGaD
Dabrafenib—BRAF—Disease—BAD—adrenal gland cancer	2.92e-05	0.000235	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CDC42—adrenal gland cancer	2.9e-05	0.000233	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	2.88e-05	0.000232	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—RRM1—adrenal gland cancer	2.85e-05	0.000229	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—SDHD—adrenal gland cancer	2.85e-05	0.000229	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IGF2—adrenal gland cancer	2.83e-05	0.000228	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	2.83e-05	0.000228	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—GNAS—adrenal gland cancer	2.8e-05	0.000226	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—CTNNB1—adrenal gland cancer	2.8e-05	0.000226	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IGF1R—adrenal gland cancer	2.73e-05	0.00022	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PRKACA—adrenal gland cancer	2.7e-05	0.000217	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	2.65e-05	0.000214	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.64e-05	0.000212	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PRKACA—adrenal gland cancer	2.5e-05	0.000201	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—RRM1—adrenal gland cancer	2.48e-05	0.0002	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—SDHD—adrenal gland cancer	2.48e-05	0.0002	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CTNNB1—adrenal gland cancer	2.48e-05	0.000199	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—PRKACA—adrenal gland cancer	2.39e-05	0.000193	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SDHB—adrenal gland cancer	2.37e-05	0.000191	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TERT—adrenal gland cancer	2.35e-05	0.00019	CbGpPWpGaD
Dabrafenib—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.34e-05	0.000188	CbGpPWpGaD
Dabrafenib—RAF1—Disease—TERT—adrenal gland cancer	2.33e-05	0.000187	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	2.24e-05	0.00018	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—EGFR—adrenal gland cancer	2.22e-05	0.000179	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—POMC—adrenal gland cancer	2.21e-05	0.000178	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—BAD—adrenal gland cancer	2.19e-05	0.000176	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—POMC—adrenal gland cancer	2.19e-05	0.000176	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GNAS—adrenal gland cancer	2.19e-05	0.000176	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PTGS2—adrenal gland cancer	2.15e-05	0.000173	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—ABCB1—adrenal gland cancer	2.14e-05	0.000173	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—MED12—adrenal gland cancer	2.12e-05	0.000171	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—BAD—adrenal gland cancer	2.05e-05	0.000165	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CDC42—adrenal gland cancer	2.03e-05	0.000163	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GNAS—adrenal gland cancer	2.02e-05	0.000163	CbGpPWpGaD
Dabrafenib—RAF1—Disease—BAD—adrenal gland cancer	2.02e-05	0.000163	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—ABCB1—adrenal gland cancer	1.99e-05	0.00016	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—EGFR—adrenal gland cancer	1.96e-05	0.000158	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IGF2—adrenal gland cancer	1.96e-05	0.000158	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—GNAS—adrenal gland cancer	1.94e-05	0.000156	CbGpPWpGaD
Dabrafenib—BRAF—Disease—CTNNB1—adrenal gland cancer	1.92e-05	0.000155	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.9e-05	0.000153	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IGF1R—adrenal gland cancer	1.89e-05	0.000152	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—POMC—adrenal gland cancer	1.89e-05	0.000152	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—EGFR—adrenal gland cancer	1.88e-05	0.000152	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.88e-05	0.000151	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—MED12—adrenal gland cancer	1.85e-05	0.000149	CbGpPWpGaD
Dabrafenib—RAF1—Disease—BRAF—adrenal gland cancer	1.84e-05	0.000148	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TP53—adrenal gland cancer	1.83e-05	0.000147	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PTGS2—adrenal gland cancer	1.75e-05	0.000141	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TERT—adrenal gland cancer	1.63e-05	0.000131	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	1.55e-05	0.000125	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.53e-05	0.000123	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.53e-05	0.000123	CbGpPWpGaD
Dabrafenib—BRAF—Disease—EGFR—adrenal gland cancer	1.52e-05	0.000123	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.51e-05	0.000122	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PTGS2—adrenal gland cancer	1.49e-05	0.00012	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—POMC—adrenal gland cancer	1.47e-05	0.000118	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CTNNB1—adrenal gland cancer	1.44e-05	0.000116	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—BAD—adrenal gland cancer	1.42e-05	0.000114	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—POMC—adrenal gland cancer	1.36e-05	0.00011	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.35e-05	0.000109	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CTNNB1—adrenal gland cancer	1.35e-05	0.000108	CbGpPWpGaD
Dabrafenib—RAF1—Disease—CTNNB1—adrenal gland cancer	1.33e-05	0.000107	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—POMC—adrenal gland cancer	1.31e-05	0.000105	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—BRAF—adrenal gland cancer	1.29e-05	0.000104	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GNAS—adrenal gland cancer	1.26e-05	0.000101	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—EGFR—adrenal gland cancer	1.25e-05	0.000101	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	1.23e-05	9.92e-05	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTGS2—adrenal gland cancer	1.17e-05	9.45e-05	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—EGFR—adrenal gland cancer	1.14e-05	9.2e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.14e-05	9.18e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.09e-05	8.81e-05	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTGS2—adrenal gland cancer	1.09e-05	8.75e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—EGFR—adrenal gland cancer	1.07e-05	8.6e-05	CbGpPWpGaD
Dabrafenib—RAF1—Disease—EGFR—adrenal gland cancer	1.05e-05	8.49e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CTNNB1—adrenal gland cancer	9.32e-06	7.51e-05	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TP53—adrenal gland cancer	8.96e-06	7.22e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—POMC—adrenal gland cancer	8.46e-06	6.81e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	8.32e-06	6.7e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—EGFR—adrenal gland cancer	7.39e-06	5.95e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—POMC—adrenal gland cancer	7.37e-06	5.93e-05	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	6.74e-06	5.43e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GNAS—adrenal gland cancer	6.74e-06	5.43e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	6.61e-06	5.33e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TP53—adrenal gland cancer	6.2e-06	4.99e-05	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTGS2—adrenal gland cancer	5.88e-06	4.73e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—POMC—adrenal gland cancer	4.54e-06	3.65e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	3.62e-06	2.91e-05	CbGpPWpGaD
